Wenjin Chen
1665 Kongjiang Road
Shanghai, 200092, China
Shanghai, 200092, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
LGALS1 promotes the malignant progression and sunitinib resistance of clear cell renal cell carcinoma by reprogramming fatty acid metabolism.
Journal: International immunopharmacology
Published: April 26, 2026
ALOX5 mediates sunitinib resistance in renal cell carcinoma by reprogramming lipid metabolism through the p38/ERK/PPARα axis.
Journal: International immunopharmacology
Published: April 14, 2026
Bile acid metabolism and hepatocellular carcinoma: mechanisms of drug resistance and intervention strategies.
Journal: Precision clinical medicine
Published: June 06, 2025
Tissue-Derived Extracellular Vesicles Define Diagnostic Biomarkers for Renal Cell Carcinoma.
Journal: Journal of extracellular vesicles
Published: April 04, 2025
Immunogenic Material Vaccine for Cancer Immunotherapy by Structure-Dependent Immune Cell Trafficking and Modulation.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: February 19, 2024
Microbiome subsets determine tumor prognosis and molecular characteristics of clear-cell renal cell carcinoma: a multi-center integrated analysis of microbiome, metabolome, and transcriptome data.
Journal: Frontiers of medicine
Published: May 08, 2023
Glycolysis-related biomarker TCIRG1 participates in regulation of renal cell carcinoma progression and tumor immune microenvironment by affecting aerobic glycolysis and AKT/mTOR signaling pathway.
Journal: Cancer cell international
Published: April 21, 2023
FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity.
Journal: BMC cancer
Published: June 28, 2021
RCC Immune Microenvironment Subsequent to Targeted Therapy: A Friend or a Foe?
Journal: Frontiers in oncology
Published: June 17, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026